Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)
Condition: Peripheral T Cell Lymphoma Intervention: Genetic: 84-gene penal Sponsors: Ruijin Hospital; West China Hospital; Shandong Provincial Hospital; RenJi Hospital; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Tianjin Medical University Cancer Institute and Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
A Phase Ib/II Study of GFH009 Monotherapy in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Condition: Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) Intervention: Drug: GFH009 Sponsor: Zhejiang Genfleet Therapeutics Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)
Condition: Peripheral T Cell Lymphoma Intervention: Genetic: 84-gene penal Sponsors: Ruijin Hospital; West China Hospital; Shandong Provincial Hospital; RenJi Hospital; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Tianjin Medical University Cancer Institute and Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
A Phase Ib/II Study of GFH009 Monotherapy in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Condition: Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) Intervention: Drug: GFH009 Sponsor: Zhejiang Genfleet Therapeutics Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)
Condition: Peripheral T Cell Lymphoma Intervention: Genetic: 84-gene penal Sponsors: Ruijin Hospital; West China Hospital; Shandong Provincial Hospital; RenJi Hospital; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Tianjin Medical University Cancer Institute and Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
A Phase Ib/II Study of GFH009 Monotherapy in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Condition: Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) Intervention: Drug: GFH009 Sponsor: Zhejiang Genfleet Therapeutics Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)
Condition: Peripheral T Cell Lymphoma Intervention: Genetic: 84-gene penal Sponsors: Ruijin Hospital; West China Hospital; Shandong Provincial Hospital; RenJi Hospital; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Tianjin Medical University Cancer Institute and Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
A Phase Ib/II Study of GFH009 Monotherapy in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Condition: Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) Intervention: Drug: GFH009 Sponsor: Zhejiang Genfleet Therapeutics Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)
Condition: Peripheral T Cell Lymphoma Intervention: Genetic: 84-gene penal Sponsors: Ruijin Hospital; West China Hospital; Shandong Provincial Hospital; RenJi Hospital; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Tianjin Medical University Cancer Institute and Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
A Phase Ib/II Study of GFH009 Monotherapy in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Condition: Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) Intervention: Drug: GFH009 Sponsor: Zhejiang Genfleet Therapeutics Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)
Condition: Peripheral T Cell Lymphoma Intervention: Genetic: 84-gene penal Sponsors: Ruijin Hospital; West China Hospital; Shandong Provincial Hospital; RenJi Hospital; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Tianjin Medical University Cancer Institute and Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials